113
Participants
Start Date
January 28, 2019
Primary Completion Date
January 28, 2023
Study Completion Date
January 28, 2023
TJ202 and Dexamethasone
one dose of TJ202 16 mg/kg or an adjusted dose will be administered on Day 1 and Day 4 of Week 1, then every week from Week 2 to Week 12, then every 2 weeks from Week 13 to Week 24 and then every 4 weeks thereafter, until the subjects experience an onset of endpoint events like intolerance or PD. DEX 40 mg will be administered on Day 1 and Day 4 of Week 1, respectively and then 40mg weekly thereafter.
Taipei Veterans General Hospital, Taipei
Beijing Chao-Yang Hospital,Capital medical university, Beijing
Peking Union Medical College Hospital, Beijing
Fujian Medical University Union Hospital, Fuzhou
Nanfang Hospital of SMU, Guangzhou
The second people's Hospital of Shenzhen, Shenzhen
Sun Yat-sen University Cancer Center, Guangzhou
Henan Cancer Hospital, Zhengzhou
Jiangsu Province Hospital, Nanjing
The first Bethune hospital of Jilin University, Changchun
Shanghai Changzheng Hospital, Shanghai
National Taiwan University Hospital, Taiwan
Tri-Service General Hospital, Taiwan
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Tianjin Medical University General Hospital, Tianjin
Sir Run Run Shaw Hospital，affiliated with the Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital, College of Medicine,Zhejiang University, Hangzhou
TJ Biopharma Co., Ltd.
INDUSTRY